Accurate Malaria P. F. Test Cassette by QL Biotech

Short Description:

The Leishmania IgG/IgM Rapid Test is a lateral flow immunoassay for the qualitative detection of antibodies including IgG and IgM to the subspecies of the Leishmania donovani (L. donovani), the Visceral leishmaniasis causative protozoans in human serum or plasma. This test is intended to be used as a screening test and as an aid in the diagnosis of the disease of Visceral leishmaniasis. Any reactive specimen with the Leishmania IgG/IgM Rapid Test must be confirmed with alternative testing method(s).


Product Detail

Product Tags

In the realm of medical diagnostics, the rapid and accurate identification of infectious diseases is paramount for effective treatment and control. QL Biotech stands at the forefront of this battle against disease with our innovative diagnostic solutions. Among our proud advancements, the Leishmania IgG/IgM Rapid Test Device has set a new benchmark in the field. However, recognizing the pressing global challenge posed by malaria, we have expanded our portfolio to include the Malaria P. F. Test Cassette, an essential tool in the fight against this deadly disease. Malaria, caused by the Plasmodium falciparum parasite, remains a major health threat in many tropical and subtropical regions. Early detection and treatment are crucial to prevent severe complications and reduce transmission. The Malaria P. F. Test Cassette by QL Biotech is designed with this urgency in mind, offering a rapid, reliable, and qualitative detection method for the presence of Plasmodium falciparum antigens in human whole blood, serum, or plasma samples. This innovative device leverages the principle of immunochromatography, a proven method in the field of diagnostic science, to deliver results with high sensitivity and specificity, ensuring that healthcare providers can make informed decisions swiftly.

PRINCIPLE

HSV‐1 IgG/IgM (HSV-2 IgG/IgM)Test is a qualitative membrane strip based immunoassay for the detection of HSV‐1 antibodies (IgG and IgM) in Whole Blood/Serum/Plasma. The test device consists of: 1) a burgundy colored conjugate pad containing HSV recombinant envelope antigens conjugated with Colloid gold (HSV conjugates) and rabbit IgG‐gold conjugates,2) a nitrocellulose membrane strip containing two test bands (T1 and T2 bands) and a control band (C band). The T1 band is pre‐coated with the antibody for the detection of IgM anti‐HSV, T2 band is coated with antibody for the detection of IgG anti‐HSV, and the C band is pre‐coated with goat anti rabbit IgG.

When an adequate volume of test specimen is dispensed into the sample well of the test cassette, the specimen migrates by capillary action across the cassette. IgG anti‐HSV, if present in the specimen, will bind to the HSV conjugates. The immunocomplex is then captured by the reagent pre‐coated on the T2 band, forming a burgundy colored T2 band, indicating a HSV IgG positive test result and suggesting a recent or repeat infection. IgM anti‐HSV if present in the specimen will bind to the HSV conjugates. The immunocomplex is then captured by the reagent coated on the T1 band, forming a burgundy colored T1 band, indicating a HSV IgM positive test result and suggesting a fresh infection. Absence of any T bands (T1 and T2) suggests a negative result. The test contains an internal control (C band) which should exhibit a burgundy colored band of the immunocomplex of goat anti rabbit IgG/rabbit IgG‐gold conjugate regardless of the color development on any of the T bands. Otherwise, the test result is invalid and the specimen must be retested with another device.


Product Detail

Brand: QL

Specimens: : Whole Blood/Serum/Plasma

Reading time:15 minutes.

Pack:25 T

STORAGE: 2‐30°C

KIT COMPONENTS

  • Test devices
  • Droppers
  • Buffer
  • Package insert

 

PROCEDURE

    • 1. Bring the pouch to room temperature before opening it. Remove the test device from the sealed pouch and use it as soon as possible. 
      2. Place the test device on a clean and level surface. For Whole Blood, Serum or Plasma specimens: Hold the dropper vertically and transfer 2 drops of specimen (or approximately 50 µL) to the specimen well (S) of the test device, then add 1 drop of buffer for serum or plasma and 2 drops of buffer for whole blood. Start the timer. 
      For Fingerstick Whole Blood specimens: 
      To use a capillary tube: Fill the capillary tube and transfer approximately 50 µL (or 2 drops) of fingerstick whole blood specimen to the specimen well (S) of the test device, then add 2 
      drops of buffer and start the timer. 
      3. Wait for the colored line(s) to appear. Read results at 15 minutes. Do not interpret results after 30 minutes. 

    INTERPRETATION OF RESULTS



    IgMPositive:* The colored line in the control line region (C) appears and a colored line appears in test line region 2 (T2). The result is positive for Leishmania specific‐IgM antibodies.

    IgGPositive:* The colored line in the control line region (C) appears and a colored line appears in test line region 1 (T1). The result is positive for Leishmania specific‐IgG.

    IgG and IgM Positive:* The colored line in the control line region (C) appears and two colored lines should appear in test line regions 1 and 2 (T1 and T2). The color intensities of the lines do not have to match. The result is positive for IgG & IgM antibodies.

    *NOTE: The intensity of the color in the test line region(s) (T1 and/or T2) will vary depending on the concentration of Leishmania antibodies in the specimen. Therefore, any shade of color in the test line region(s) (T1 and/or T2) should be considered positive.

    The colored line in the control line region (C) appears. No line appears in test line regions 1 or 2 (T1 or T2).

    Controlline(C) falls toappear.Insufficient buffer volume or incorrect procedural techniques are the most likely reasons for control line failure.

    Review the procedure and repeat the procedure with a new test device. If the problem persists, discontinue using the test kit immediately and contact your local distributor.




    Our Malaria P. F. Test Cassette is a culmination of extensive research and cutting-edge technology, encapsulating the dedication of QL Biotech to improve global health outcomes. The test procedure is straightforward, requiring only a small sample of the patient's blood. Within minutes, the device reveals the test results, enabling a rapid response in the treatment of malaria. This efficiency is crucial in resource-limited settings where access to laboratory facilities may be restricted. Furthermore, the Malaria P. F. Test Cassette is designed for ease of use, requiring minimal training, which makes it an invaluable tool in community health programs and in the field. QL Biotech is committed to advancing healthcare through innovation. The Malaria P. F. Test Cassette is more than just a product; it is part of our broader mission to provide accessible, high-quality diagnostic solutions to those in need. By incorporating this device into malaria control programs, we can take a significant step forward in reducing the burden of this disease, saving lives, and enhancing the well-being of communities around the world.

  • Previous:
  • Next: